Non-Muscle-Invasive Bladder Cancer

This e-learning course offers an overview on transurethral resection of bladder tumor (TURB), patient risk stratification and treatment-choice for prevention of recurrent NMIBC and/or progression in order to help urologist to recognize which clinical and pathological factors are important for predicting disease recurrence and progression and understand how patients are stratified accordingly.

This course has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) for 2 European CME credits (ECMEC). Learners can download their CME certificate after completing the course.

The development of this course has been supported by Ipsen with a concession of an unrestricted educational grant.

Learning Objectives

• Understand the diverse nature of NMIBC
• Arrive at the right diagnosis of NMIBC
• Make a risk assessment of NMIBC cases
• Decide on a treatment and follow-up strategy

Learning Modules

Clinical Aspects
1. Incidence and risk factors of NMIBC
2. Definition and classification

Diagnosis and Treatment
3. Primary assessment of NMIBC
4. Transurethral resection
5. Diagnostic evaluation
6. Predicting recurrence and progression

Disease Management
7. Adjuvant treatment
8. Radical cystectomy
9. Follow up and surveillance

At a glance

• Latest update: October 2023
• Publication date: March 2016
• Available languages: English
• Topic: Non-Muscle Invasive Bladder Cancer
• Duration: Approx. 90 minutes
• CME: 2 European CME credits (ECMEC)

Contributing Authors

Main author:
Prof. dr. dr. M. Babjuk
Charles University 2nd Faculty of Medicine – Motol University Hospital. dept. of Urology. Prague (Czech Republic)

Co-Authors:
Prof. dr. dr. E. Compérat
Hôpitaux universitaires La Pitié-Salpêtrière. dept. of Pathology.
Paris (France)

dr. V. Soukup
Charles University. dept. of Urology
Prague (Czech Republic)

dr. E. Xylinas
Cochin Hospital, Paris Descartes University. dept. of Urology
Paris (France)